Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.

Share:
More In Business
Cybersecurity is Entering a New Era
Jim Guinn, EY Americas Cybersecurity Leader, shares how companies must stay vigilant and navigate the evolving regulatory landscape. *Sponsored by EY
Load More